Amantadine-Induced Craniofacial Myoclonus: Distinctive Iatrogenic Dysarthria in Parkinson's Disease.
Iris LinLaura Armengou-GarciaSanskriti SasikumarGreg KuhlmanSusan H FoxAnthony E LangAlberto J EspayPublished in: Movement disorders clinical practice (2023)
Speech-induced craniofacial myoclonus, with marked "stuttering-like" dysarthria and speech arrests, is a disabling iatrogenic complication in PD that resolves upon amantadine discontinuation.